BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17679784)

  • 1. Perspectives on prehypertension.
    Nesbitt SD
    J Cardiometab Syndr; 2006; 1(5):364-5. PubMed ID: 17679784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of treating prehypertension with an angiotensin-receptor blocker.
    Julius S; Nesbitt SD; Egan BM; Weber MA; Michelson EL; Kaciroti N; Black HR; Grimm RH; Messerli FH; Oparil S; Schork MA;
    N Engl J Med; 2006 Apr; 354(16):1685-97. PubMed ID: 16537662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating prehypertension.
    Grassi DG
    N Engl J Med; 2006 Jul; 355(4):416; author reply 417-8. PubMed ID: 16870923
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating prehypertension.
    Baumann M; van den Born BJ
    N Engl J Med; 2006 Jul; 355(4):416-8; author reply. PubMed ID: 16874901
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment options for prehypertension.
    Nesbitt SD
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):250-5. PubMed ID: 17420669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating prehypertension.
    Lopez-Plasencia Y; Amela-Peris R; Garcia-Delgado Y
    N Engl J Med; 2006 Jul; 355(4):416-7; author reply 417-8. PubMed ID: 16874902
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating prehypertension.
    Conen D; Martina B
    N Engl J Med; 2006 Jul; 355(4):417; author reply 417-8. PubMed ID: 16871687
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
    Mann J
    Internist (Berl); 2007 Apr; 48(4):436-8. PubMed ID: 17342351
    [No Abstract]   [Full Text] [Related]  

  • 9. [CASE-J].
    Fukui T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():449-53. PubMed ID: 16981578
    [No Abstract]   [Full Text] [Related]  

  • 10. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
    Meredith PA
    Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the results of TROPHY affect the JNC 7 definition of prehypertension?
    Julius S
    Curr Hypertens Rep; 2007 Jun; 9(3):202-5. PubMed ID: 17519125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevension of hypertension by angiotensin receptor blockers in human--TROPHY study].
    Ohya Y; Inoue T
    Nihon Rinsho; 2008 Aug; 66(8):1596-600. PubMed ID: 18700563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for prehypertension--mission accomplished?
    Schunkert H
    N Engl J Med; 2006 Apr; 354(16):1742-4. PubMed ID: 16537661
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY).
    Williams SA; Michelson EL; Cain VA; Yang M; Nesbitt SD; Egan BM; Julius S;
    J Clin Hypertens (Greenwich); 2008 Jun; 10(6):436-42. PubMed ID: 18550933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of treating prehypertension with an angiotensin-receptor blocker--results from TROPHY study].
    Umemura S
    Nihon Rinsho; 2008 Mar; 66(3):601-9. PubMed ID: 18326331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
    Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of Cardiovascular Complications in Patients With Arterial Hypertension While Use of Angiotensin II Receptor Antagonists. Possibilities of Candesartan].
    Savina NM
    Kardiologiia; 2016 Jun; 56(6):63-67. PubMed ID: 28290850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.
    Ogihara T; Nakao K; Fukui T; Fukiyama K; Ueshima K; Oba K; Sato T; Saruta T;
    Hypertension; 2008 Feb; 51(2):393-8. PubMed ID: 18172059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From TROPHY with pride.
    Julius S; Schork A; Egan BM
    Am J Hypertens; 2007 Mar; 20(3):342-3; author reply 343-5. PubMed ID: 17324750
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.